ALKERMES | ALKS - Ordinary Share Capital

ALKERMES reported $1.69M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Coherus Biosciences CHRS:US USD 8K 1000
Heron Therapeutics HRTX:US USD 1.19M 163K
Horizon Pharma HZNP:US USD 23K 0
Intra Cellular Therapies ITCI:US USD 9K 0
IONIS PHARMACEUT IONS:US USD 142K 0
JAZZ PHA JAZZ:US USD 61K 0
Marinus Pharmaceuticals MRNS:US USD 50K 13K
Minerva Neurosciences NERV:US USD 1000 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Otsuka Holdings 4578:JP JPY 81.69B 0
Revance Therapeutics RVNC:US USD 82K 0
Teva Pharmaceutical Industries TEVA:US USD 57M 0